ATE431337T1 - Kristallisation und aufreinigung von glykopyrroniumbromid - Google Patents

Kristallisation und aufreinigung von glykopyrroniumbromid

Info

Publication number: ATE431337T1
Authority: AT; Austria
Prior art keywords: diastereoisomers; crystallization; purification; glycopyrronium bromide; solvent
Prior art date: 2005-03-03

Application number

AT06709993T

Other languages

English (en)

Inventor

Andrew Douglas Baxter

Kenneth Walter Sinden

Stefan Kleinebekel

Original Assignee

Sosei R & D Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-03

Filing date

2006-03-03

Publication date

2009-05-15

2006-03-03 Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd

2009-05-15 Application granted granted Critical

2009-05-15 Publication of ATE431337T1 publication Critical patent/ATE431337T1/de

Links

229960002462 glycopyrronium bromide Drugs 0.000 title abstract 3
238000002425 crystallisation Methods 0.000 title abstract 2
230000008025 crystallization Effects 0.000 title abstract 2
VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 title 1
238000000746 purification Methods 0.000 title 1
GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
239000002904 solvent Substances 0.000 abstract 2
ANGKOCUUWGHLCE-UHFFFAOYSA-N 2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester Chemical compound C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 ANGKOCUUWGHLCE-UHFFFAOYSA-N 0.000 abstract 1
ANGKOCUUWGHLCE-HKUYNNGSSA-N [(3s)-1,1-dimethylpyrrolidin-1-ium-3-yl] (2r)-2-cyclopentyl-2-hydroxy-2-phenylacetate Chemical compound C1[N+](C)(C)CC[C@@H]1OC(=O)[C@](O)(C=1C=CC=CC=1)C1CCCC1 ANGKOCUUWGHLCE-HKUYNNGSSA-N 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229940102396 methyl bromide Drugs 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Pyrrole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Silicates, Zeolites, And Molecular Sieves (AREA)
Medicinal Preparation (AREA)

AT06709993T 2005-03-03 2006-03-03 Kristallisation und aufreinigung von glykopyrroniumbromid ATE431337T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0504463.1A GB0504463D0 (en)	2005-03-03	2005-03-03	Method of crystallisation and purification
PCT/GB2006/000770 WO2006092617A1 (en)	2005-03-03	2006-03-03	Crystallisation and purification of glycopyrronium bromide

Publications (1)

Publication Number	Publication Date
ATE431337T1 true ATE431337T1 (de)	2009-05-15

Family

ID=34451780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06709993T ATE431337T1 (de)	2005-03-03	2006-03-03	Kristallisation und aufreinigung von glykopyrroniumbromid

Country Status (20)

Country	Link
US (1)	US8846954B2 (de)
EP (1)	EP1856041B1 (de)
JP (1)	JP5319119B2 (de)
KR (1)	KR101267108B1 (de)
CN (1)	CN101133021B (de)
AT (1)	ATE431337T1 (de)
AU (1)	AU2006219727B2 (de)
BR (1)	BRPI0609057A2 (de)
CA (1)	CA2601129C (de)
DE (1)	DE602006006808D1 (de)
DK (1)	DK1856041T3 (de)
ES (1)	ES2326132T3 (de)
GB (1)	GB0504463D0 (de)
IL (1)	IL185576A (de)
MX (1)	MX2007010729A (de)
NO (1)	NO340220B1 (de)
NZ (1)	NZ561293A (de)
PT (1)	PT1856041E (de)
WO (1)	WO2006092617A1 (de)
ZA (1)	ZA200707512B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090005577A1 (en) *	2007-06-29	2009-01-01	Nikolai Kraiouchkine	Method of producing 1-substituted 3-pyrrolates
PL2417106T3 (pl)	2009-04-09	2017-05-31	Novartis Ag	Sposób wytwarzania soli pirolidyniowych
EP2580195B1 (de) *	2010-06-14	2014-12-03	Chiesi Farmaceutici S.p.A.	Kristall aus glycopyrroniumchlorid
CN103159659A (zh) *	2011-12-19	2013-06-19	沈阳药科大学	一种毒蕈碱受体拮抗剂格隆溴铵的制备方法
CN102627595A (zh) *	2012-03-09	2012-08-08	徐奎	一种制备格隆溴铵的方法
US8558008B2 (en)	2013-02-28	2013-10-15	Dermira, Inc.	Crystalline glycopyrrolate tosylate
KR20150119468A (ko)	2013-02-28	2015-10-23	더미라, 인코포레이티드	글리코피롤레이트 염
US9006462B2 (en)	2013-02-28	2015-04-14	Dermira, Inc.	Glycopyrrolate salts
CN103553996B (zh) *	2013-11-13	2016-01-20	北京三泉医药技术有限公司	抗胆碱药物组合物
US9926270B2 (en)	2014-08-20	2018-03-27	Dermira, Inc.	Process for production of glycopyrronium tosylate
CZ2014680A3 (cs)	2014-10-06	2016-04-13	Zentiva, K.S.	Způsob přípravy glykopyrronium bromidu
US9925168B2 (en) *	2016-01-22	2018-03-27	Chiesi Farmaceutici S.P.A.	Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
CN107345945B (zh) *	2016-05-05	2019-12-17	辽宁药联制药有限公司	一种拆分格隆溴铵对映体及杂质检查的高效液相色谱方法
PT109445B (pt) *	2016-06-08	2018-11-06	Hovione Farm Sa	Co-cristais farmacêuticos cristalinos de brometo de glicopirrónio com lactose
CN107915666A (zh) *	2016-10-09	2018-04-17	四川海思科制药有限公司	一种格隆溴铵化合物
WO2022079194A1 (en)	2020-10-14	2022-04-21	Pcas	Process for the production of glycopyrronium tosylate
CN113234003B (zh) *	2021-04-23	2024-02-02	广东嘉博制药有限公司	一种格隆溴铵及其制备方法
CN114428131B (zh) *	2021-12-27	2023-09-15	山东泰合医药科技有限公司	一种拆分格隆溴铵中间体的非对映异构体的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2956062A (en) *	1959-02-26	1960-10-11	Robins Co Inc A H	Esters of amino alcohols
DK0937041T3 (da) *	1996-11-11	2003-08-11	Christian R Noe	Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel
AT412088B (de)	2002-12-18	2004-09-27	Pharmacon Forschung & Beratung Gmbh	Verfahren zur herstellung der r,r oder s,s konfigurierten glycopyrronium-isomere

2005
- 2005-03-03 GB GBGB0504463.1A patent/GB0504463D0/en not_active Ceased
2006
- 2006-03-03 JP JP2007557594A patent/JP5319119B2/ja not_active Expired - Lifetime
- 2006-03-03 NZ NZ561293A patent/NZ561293A/en unknown
- 2006-03-03 ZA ZA200707512A patent/ZA200707512B/xx unknown
- 2006-03-03 PT PT06709993T patent/PT1856041E/pt unknown
- 2006-03-03 KR KR1020077022077A patent/KR101267108B1/ko not_active Expired - Lifetime
- 2006-03-03 MX MX2007010729A patent/MX2007010729A/es active IP Right Grant
- 2006-03-03 BR BRPI0609057-5A patent/BRPI0609057A2/pt not_active Application Discontinuation
- 2006-03-03 DK DK06709993T patent/DK1856041T3/da active
- 2006-03-03 US US11/817,166 patent/US8846954B2/en active Active
- 2006-03-03 ES ES06709993T patent/ES2326132T3/es not_active Expired - Lifetime
- 2006-03-03 CN CN2006800069015A patent/CN101133021B/zh not_active Expired - Lifetime
- 2006-03-03 AT AT06709993T patent/ATE431337T1/de active
- 2006-03-03 DE DE602006006808T patent/DE602006006808D1/de not_active Expired - Lifetime
- 2006-03-03 WO PCT/GB2006/000770 patent/WO2006092617A1/en not_active Ceased
- 2006-03-03 EP EP06709993A patent/EP1856041B1/de not_active Expired - Lifetime
- 2006-03-03 AU AU2006219727A patent/AU2006219727B2/en not_active Expired
- 2006-03-03 CA CA2601129A patent/CA2601129C/en not_active Expired - Lifetime
2007
- 2007-08-29 IL IL185576A patent/IL185576A/en active IP Right Grant
- 2007-09-10 NO NO20074558A patent/NO340220B1/no unknown

Also Published As

Publication number	Publication date
PT1856041E (pt)	2009-07-21
GB0504463D0 (en)	2005-04-13
IL185576A (en)	2011-11-30
MX2007010729A (es)	2007-11-08
HK1104817A1 (en)	2008-01-25
CN101133021B (zh)	2011-01-19
JP5319119B2 (ja)	2013-10-16
EP1856041A1 (de)	2007-11-21
NO20074558L (no)	2007-09-28
DK1856041T3 (da)	2009-08-24
KR20070113263A (ko)	2007-11-28
CN101133021A (zh)	2008-02-27
ZA200707512B (en)	2008-11-26
CA2601129C (en)	2013-04-30
NO340220B1 (no)	2017-03-20
NZ561293A (en)	2010-05-28
AU2006219727A1 (en)	2006-09-08
BRPI0609057A2 (pt)	2010-02-17
ES2326132T3 (es)	2009-10-01
CA2601129A1 (en)	2006-09-08
KR101267108B1 (ko)	2013-05-23
WO2006092617A1 (en)	2006-09-08
DE602006006808D1 (de)	2009-06-25
EP1856041B1 (de)	2009-05-13
US8846954B2 (en)	2014-09-30
US20080227988A1 (en)	2008-09-18
JP2008531674A (ja)	2008-08-14
AU2006219727B2 (en)	2010-03-04
IL185576A0 (en)	2008-01-06

Legal Events

Date

Code

Title

Description

2009-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1856041

Country of ref document: EP

Publication	Publication Date	Title
NO20074558L (no)	2007-09-28	Krystallisasjon og rensing av glykopyrroniumbromid
MXPA05012680A (es)	2006-02-08	Indoles novedosos de 3-azufre sustituidos.
MXPA05012362A (es)	2006-02-02	Yodopirazolilcarboxanilidas.
UA81567C2 (en)	2008-01-10	Heteroaroyl-substituted phenylalanine amides
TW200505920A (en)	2005-02-16	Organic compounds
DE602004013405D1 (de)	2008-06-12	Polymorphe formen von valsartan
TW200732335A (en)	2007-09-01	Organic compounds
DE602004024213D1 (en)	2009-12-31	Aminopropanolderivate
PL1891004T3 (pl)	2010-05-31	Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
IL174469A0 (en)	2006-08-01	Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
GT200300095A (es)	2004-01-15	Derivados de isoquinolina
ATE501153T1 (de)	2011-03-15	Kristallisation von festen formen von clopidogreladditionssalzen
IS2979B (is)	2017-09-15	Aðferð til að framleiða N-útskipt 2-sýanópýrrólídín
BRPI0519292A2 (pt)	2009-01-06	compostos orgÂnicos
TW200732337A (en)	2007-09-01	Organic compounds
DE50310579D1 (de)	2008-11-13	Furancarboxamide
DE602004020916D1 (de)	2009-06-10	Verfahren zum Herstellen von hochreinem Hafnium
WO2007065684A3 (en)	2007-08-02	Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents
GB0428416D0 (en)	2005-02-02	Organic compounds
TNSN07133A1 (en)	2008-11-21	Heteroatoms-containing tricyclic compounds
WO2006061215A3 (de)	2006-11-02	2-alkyl-cycloalk(en)yl-carboxamide
DE50311756D1 (de)	2009-09-10	Mikrobizide oxathiincarboxamide
WO2007116011A3 (de)	2007-12-21	Substituierte triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
DE602006003204D1 (de)	2008-11-27	Reinigungsverfahren von Moxonidine
UA91565C2 (en)	2010-08-10	Thiazols, use of thiazols as fungicides